As noted, it was previously reported that NR2F6 global KO mice harboring mouse melanoma and colon cancer models showed enhanced responses to programmed death-ligand 1/PD-1 ICT relative to comparable WT mice (32). This evidence concerns the gene NR2F6 and melanoma.